Epigenomics Launches Study of Cancer Test Adoption Patterns

The firm expects the study to include around 300 primary care physicians and up to 3,000 patients getting the Epi proColon test in Germany and Switzerland.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.